(Q74450936)

English

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

scientific article published on 01 November 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

T Fischer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T D Szucs

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1894-1901

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Current drug treatment guidelines for epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced epithelial ovarian cancer: 1993 consensus statements

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource implications of palliative chemotherapy for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900260-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00260-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10023312%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74450936&oldid=1739481387"